FindTrial
Sign In

Radioembolization

RADIATION6 trials

Sponsors

Rocky Mountain Cancer Centers, M.D. Anderson Cancer Center, City of Hope Medical Center, Seoul National University Hospital, UMC Utrecht

Conditions

Bile Duct AdenocarcinomaColorectal Cancer MetastaticHepatocellular CarcinomaMetastatic Liver CarcinomaStage I Renal Cell CancerStage II Renal Cell CancerStage III Intrahepatic CholangiocarcinomaStage IV Liver Cancer

Phase 1

Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer
Active, not recruitingNCT03028311
M.D. Anderson Cancer CenterMetastatic Liver Carcinoma, Stage IVA Liver Cancer, Stage IVB Liver Cancer +1
Start: 2017-01-09End: 2027-01-31Target: 12Updated: 2026-03-10
Capecitabine and Y-90 Radioembolization in Treating Patients With Advanced Bile Duct Cancer in the Liver That Cannot Be Removed by Surgery
WithdrawnNCT03117855
City of Hope Medical CenterBile Duct Adenocarcinoma, Stage III Intrahepatic Cholangiocarcinoma, Stage IVA Intrahepatic Cholangiocarcinoma +1
Start: 2016-12-31Updated: 2017-04-18
Safety and Efficacy Study of Radioembolization in Combination With Durvalumab in Locally Advanced and Unresectable HCC
CompletedNCT04124991
Seoul National University HospitalHepatocellular Carcinoma
Start: 2020-06-12End: 2022-07-28Updated: 2023-03-16
Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial
RecruitingNCT06432036
Jonsson Comprehensive Cancer CenterStage II Renal Cell Cancer, Stage I Renal Cell Cancer
Start: 2024-12-26End: 2027-06-01Target: 25Updated: 2026-03-06

Phase 2

Definitive Therapy for Oligometastatic Solid Malignancies
NCT01898962
Rocky Mountain Cancer CentersStage IV or Recurrent Carcinoma or Sarcoma
Start: 2005-12-31End: 2018-12-31Target: 110Updated: 2013-07-15
Radioembolization in Elderly/ Fragile Patients With mCRC
RecruitingNCT05092880
UMC UtrechtColorectal Cancer Metastatic
Start: 2022-06-01End: 2028-10-31Target: 220Updated: 2023-12-19